On Friday 13 March, Erganeo and start-up Evora Biosciences signed a world-exclusive license agreement for a new-generation digestive fistula cellular therapy treatment. Picture from left to right: Naceur Tounekti, Vice-President of Erganeo and Hadrien Lanvin, CEO of Evora Biosciences A condition with serious consequences, and complex cases that are inadequately treated An estimated 1.2 million […]
